INTERCEPT PHARMA LTD
BRISTOL

Hellopages » Bristol » Bristol, City of » BS2 0ZX

Company number 10152652
Status Active
Incorporation Date 28 April 2016
Company Type Private Limited Company
Address ONE, GLASS WHARF, BRISTOL, UNITED KINGDOM, BS2 0ZX
Home Country United Kingdom
Nature of Business 46460 - Wholesale of pharmaceutical goods
Phone, email, etc

Since the company registration three events have happened. The last three records are Confirmation statement made on 30 September 2016 with updates; Current accounting period shortened from 30 April 2017 to 31 December 2016; Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2016-04-28 GBP 2 . The most likely internet sites of INTERCEPT PHARMA LTD are www.interceptpharma.co.uk, and www.intercept-pharma.co.uk. The predicted number of employees is 1 to 10. The company’s age is nine years and six months. Intercept Pharma Ltd is a Private Limited Company. The company registration number is 10152652. Intercept Pharma Ltd has been working since 28 April 2016. The present status of the company is Active. The registered address of Intercept Pharma Ltd is One Glass Wharf Bristol United Kingdom Bs2 0zx. . QUAYSECO LIMITED is a Secretary of the company. HIGSON, Graham Charles is a Director of the company. HOOD, Daniel Carey Cazel is a Director of the company. ROBERTSON, Linda Marontate, Dr is a Director of the company. YOON, Seokho Bryan is a Director of the company. The company operates in "Wholesale of pharmaceutical goods".


Current Directors

Secretary
QUAYSECO LIMITED
Appointed Date: 28 April 2016

Director
HIGSON, Graham Charles
Appointed Date: 28 April 2016
69 years old

Director
HOOD, Daniel Carey Cazel
Appointed Date: 28 April 2016
52 years old

Director
ROBERTSON, Linda Marontate, Dr
Appointed Date: 28 April 2016
67 years old

Director
YOON, Seokho Bryan
Appointed Date: 28 April 2016
48 years old

Persons With Significant Control

Intercept Pharmaceuticals, Inc.
Notified on: 28 April 2016
Nature of control: Ownership of shares – 75% or more

INTERCEPT PHARMA LTD Events

30 Sep 2016
Confirmation statement made on 30 September 2016 with updates
25 May 2016
Current accounting period shortened from 30 April 2017 to 31 December 2016
28 Apr 2016
Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2016-04-28
  • GBP 2